Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Dashan Yin
Institutions:
Zhejiang Hospital,
Zhejiang University
Observed institutions:
Zhejiang Hospital,
Zhejiang University
ORCID:
0009-0005-0464-3024
Observed ORCID:
0009-0005-0464-3024
OpenAlex ID:
A5113430612
Patient-Derived Organoids as a Platform to Decipher and Overcome Radioresistance: From the Tumor Microenvironment to Radiosensitizer Discovery
2025
·
Dashan Yin
, Xiujuan Hong
, et al.
·
Current Oncology
·
7
PDF
Infrared radiation for cancer hyperthermia: the light to brighten up oncology
2024
·
Mengna Ye
, Dashan Yin
, et al.
·
Expert Review of Anticancer Therapy
·
2
Reprogramming PD-L1 endosomal recycling and lysosomal degradation via engineered exosome-based nanocomposites overcomes immune resistance in lung cancer brain metastasis
2026
·
Xiujuan Hong
, Xiaoqi Wang
, et al.
·
Materials Today Bio
Causal effects of drug exposure on gastric cancer risk: a Mendelian randomization study involving 23 commonly used medications in the European population
2026
·
Ganlu Zhang
, Jindan Xia
, et al.
·
Discover Oncology
Endostar combined with docetaxel or cisplatin in the management of malignant ascites through hyperthermic intraperitoneal chemotherapy: A retrospective cohort study
2026
·
Jing Wu
, Dashan Yin
, et al.
·
Oncology Letters
PDF
Establishment of Patient-Derived Organoid Model from Hydrothorax and Ascites
2023
·
Dashan Yin
, Yajun Wu
, et al.
·
Journal of Organoid and Bioscience
PDF
Show more works
View as search
Works count:
6
Citation count:
9
H-index:
2
I10-index:
Year
Topic
Type